Ligand validation:6CE2

PE4: 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6CE2_PE4_A_201	22%	79%	0.228	0.908	0.59	0.28	-	-	3	0	67%	0.6667
6CE2_PE4_B_201	20%	79%	0.166	0.826	0.63	0.24	-	-	2	0	67%	0.6667
3T0R_PE4_A_134	5%	69%	0.332	0.753	0.67	0.52	-	-	9	0	100%	1
7EHR_PE4_A_508	89%	93%	0.073	0.951	0.19	0.3	-	-	0	0	100%	1
7OE4_PE4_AAA_505	89%	96%	0.081	0.958	0.18	0.16	-	-	0	0	100%	1
3EBW_PE4_B_5747	87%	50%	0.086	0.973	0.76	1.16	-	1	3	0	92%	0.9167
4QIB_PE4_A_201	81%	57%	0.093	0.946	0.71	0.93	-	1	0	0	100%	1
7NQ5_PE4_AAA_504	81%	96%	0.093	0.943	0.14	0.23	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.